US Patent Issued to ILIAS BIOLOGICS, ILIAS THERAPEUTICS on Feb. 3 for "Exosomes for target specific delivery and methods for preparing and delivering the same" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,325, issued on Feb. 3, was assigned to ILIAS BIOLOGICS INC. (Daejeon, South Korea) and ILIAS THERAPEUTICS INC..

"Exosomes for target specific delivery and methods for preparing and delivering the same" was invented by Chulhee Choi (Daejeon, South Korea), Nambin Yim (Daejeon, South Korea), Hojun Choi (Daejeon, South Korea), Kyungsun Choi (Daejeon, South Korea) and Seung-Wook Ryu (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for producing an exosome that transfers an active substance specifically to a target and the exosome produced by the same; a method for delivering the active substance ...